Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
URTH vs XBI: how they differ
URTH and XBI hold 1% of their weight in the same names, and XBI returned more over the year.
iShares MSCI World ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF.
What they hold in common
By the books each fund has filed, URTH and XBI hold 1% of their money in the same securities at the same weight.
| Holding | URTH | XBI |
|---|---|---|
| ABBVIE INC. | 0.42% | 1.04% |
| AMGEN INC. | 0.20% | 1.00% |
| GILEAD SCIENCES, INC. | 0.18% | 0.97% |
| VERTEX PHARMACEUTICALS INCORPORATED | 0.13% | 1.06% |
| REGENERON PHARMACEUTICALS, INC. | 0.07% | 0.96% |
| ALNYLAM PHARMACEUTICALS, INC. | 0.04% | 0.96% |
| BIOGEN INC. | 0.03% | 1.03% |
| NATERA, INC. | 0.03% | 1.17% |
| REVOLUTION MEDICINES, INC. | 0.03% | 1.21% |
| UNITED THERAPEUTICS CORPORATION | 0.03% | 0.93% |
| INSMED INCORPORATED | 0.03% | 1.08% |
| INCYTE CORPORATION | 0.02% | 1.00% |
| Only in URTH | Only in XBI |
|---|---|
| NVIDIA CORPORATION 5.64% | Apogee Therapeutics Inc 1.49% |
| APPLE INC. 5.04% | Moderna Inc 1.41% |
| MICROSOFT CORPORATION 3.50% | Twist Bioscience Corp 1.41% |
| AMAZON.COM, INC. 2.86% | Oruka Therapeutics Inc 1.38% |
| ALPHABET INC. 2.43% | Kymera Therapeutics Inc 1.36% |
| BROADCOM INC. 2.21% | Viking Therapeutics Inc 1.31% |
| ALPHABET INC. 2.01% | Praxis Precision Medicines Inc 1.29% |
| META PLATFORMS, INC. 1.51% | Erasca Inc 1.27% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
| URTH iShares MSCI World ETF | XBI State Street(R) SPDR(R) S&P(R) Biotech ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | MSCI World | SPDR S&P Biotech |
| Total return, 1 year | +17.4% | +64.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −0.1 pts | +46.5 pts |
| Expense ratio | 0.24% | 0.35% |
| Already in the S&P 500 | 70.3% | 8.5% |
| Holdings | 1322 | 150 |
URTH in plain words
URTH is an index equity fund tracking the MSCI World. Over the year to Sep 11, 2026 it returned +17.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.24% a year. By its holdings filed for May 31, 2026, 70% of the fund by weight is stocks the S&P 500 also holds, across 1322 positions, with the top ten at 27.8%.
XBI in plain words
XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, URTH or XBI?
- In the year to Sep 12, 2026, with distributions reinvested, URTH returned +17.4% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, URTH or XBI?
- URTH charges 0.24% a year and XBI charges 0.35%, so URTH is cheaper. Fees come from each fund's prospectus.
- How much do URTH and XBI overlap with the S&P 500?
- By their latest filed holdings, 70% of URTH and 8% of XBI by weight is stocks the S&P 500 already holds. Between the two funds, 1% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, URTH against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/URTH-XBI Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources